Bronchopulmonary Dysplasia Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia
Condition: Bronchopulmonary Dysplasia Intervention: Drug: Evaluation at 24 months corrected age: respiratory outcome, Neurodevelopmental outcome, Growth outcome Sponsor: Hospices Civils de Lyon Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2021 Category: Research Source Type: clinical trials
